Search datasets
-
Vitrakvi (larotrectinib) is an oral solution that inhibits tropomyosin receptor kinases, prescribed for certain cancers with NTRK gene fusions. It's a 20 mg/mL concentrate manufactured by Bayer...
Search relevance: 172.63 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 08:14 PM